1.
Clin Transplant
; 23(5): 705-9, 2009.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19637991
RESUMO
This report illustrates potential concerns regarding the administration of Argatroban (AGN), a small molecule, direct thrombin inhibitor, within the setting of multi-organ procurement (MOP). Herein, we outline the case of a large AGN bolus to the donor during MOP, and the passive transfer of a coagulopathy to the recipient of the transplanted liver. From this, we conclude that caution should be exercised when AGN is used in the setting of MOP.